SRPT
NASDAQ · Biotechnology
Sarepta Therapeutics Inc
$16.88
+0.10 (+0.60%)
Open$16.88
Previous Close$16.78
Day High$16.89
Day Low$16.87
52W High$25.32
52W Low$14.68
Volume—
Avg Volume3.39M
Market Cap1.81B
P/E Ratio27.89
EPS$0.07
SectorBiotechnology
Analyst Ratings
Hold
34 analysts
Price Target
+135.8% upside
Current
$16.88
$16.88
Target
$39.80
$39.80
$34.71
$39.80 avg
$61.57
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 2.36B | 1.77B | 549.72M |
| Net Income | -766,021,811 | -518,087,946 | -107,586,925 |
| Profit Margin | -32.5% | -30.8% | -19.6% |
| EBITDA | -730,470,143 | -521,489,919 | -125,300,242 |
| Free Cash Flow | — | — | -79,607,758 |
| Rev Growth | +33.1% | +33.1% | +15.5% |
| Debt/Equity | 0.73 | 0.73 | 0.72 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $246.04 | +0.89% | 118.6 | 430.95B |
| AMGN | Amgen Inc | $410.95 | +1.51% | 25.1 | 219.39B |
| GILD | Gilead Sciences Inc | $133.21 | +1.80% | — | 165.85B |
| VRTX | Vertex Pharmaceuticals Inc | $496.07 | +2.49% | 28.3 | 124.51B |
| REGN | Regeneron Pharmaceuticals | $784.36 | +1.59% | 18.4 | 79.53B |
| ALNY | Alnylam Pharmaceuticals Inc | $219.20 | +1.43% | 35.2 | 28.41B |